Carnitine: Improves fat metabolism, enhances energy levels, reduces recovery times and boosts muscle-building potential
2031 Cognitive Assessment in Schizophrenia: A Landscape Review of Instruments and Core Domains Angela Stroupe 1 , Chris Buckley 2 , Alessandra Girardi 3 , Zorana Zupan 4 1 Parexel, Boston, Massachusetts, USA, 2 Parexel, London, UK, 3 Parexel, Rome, Italy, 4 Parexel, Belgrade, Serbia Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :2031 Aims Cognitive impairment, affecting up to 45% of schizophrenia patients, remains the least addressed core symptom
Abbreviations GLP-1, glucagon-like peptide-1
thus, it may induce hypoglycemia and it is contraindicated in patients with advanced liver insufficiency.66 In contrast, the pharmacodynamics of nateglinide is not altered in patients with CLD and is thus expected to be safer.67 Incretin-based therapies Incretin-based therapies comprise injectable glucagon-like peptide-1 (GLP-1) receptor agonists and oral inhibitors of dipeptidylpeptidase-4 (DPP-4)(gliptins)
People were divided into estrogen levels according to the median estrogen level in the 100 days prior to medication start, divided into the same bins as in the previous section (n=2337)
